Finance
featured
ThoughtSpot has raised $60 million in new venture funding to automate the work of business analysts. » Read More
By: Evelyn Cheng
Bitcoin climbed above $4,500 to a record high Thursday, giving it a market valuation larger than that of Netflix. » Read More |
By: Thomas Franck
Bernstein upgrades Hershey to outperform, citing millennial snacking habits and falling cocoa prices. » Read More |
The "Fast Money" traders share their first moves for the market open. » Read More |
More
How Eaton Vance's Eddie Perkin is positioning his portfolio for a Trump tax cut victory.
By the charts and economic fundamentals, emerging market stocks look ready to run higher, according to Triogem's Tim Seymour.
Australia joins China and Japan in trying to regulate bitcoin and digital currency exchange providers with crackdown on money laundering.
Intel could be a technology stock worth investing in as it looks to expand its chip business in the second half, an asset portfolio manager told CNBC.
A former Bank of America technology consultant allegedly shared more than 50 trading tips with friends, according to U.S. government documents.
Check out which companies are making headlines after the bell on Wednesday: LB, CSCO, SNPS & more
NAFTA negotiations around "rules of origin" could affect supply chains and raise costs.
The latest political turmoil is spelling trouble for accomplishing anything on the Trump administration's agenda, a former national economic advisor said.
The e-commerce giant was mentioned by mall operators, a satellite TV provider, an auto parts retailer and pharmacy and drug companies.
At their meeting in July, central bank officials discussed whether the rise in equity prices was posing broader financial dangers.
A fissure appears to be developing at the Federal Reserve over when to raise interest rates.
Raising a baby doesn't come cheap and the costs of child-rearing may be more manageable in certain states.
Chinese investments in the U.S. have more than halved this year, according to Dealogic.
The "Fast Money" traders share their moves for the first hours of the trading day.
Goldman Sachs added biotech company Biogen to its Americas Conviction List, citing a 'blockbuster' drug.
The Great Recession "scarred people so significantly that they are reluctant to trust in long-term investments," Raphael Bostic tells CNBC.
Contact Finance
-
CNBC NEWSLETTERS
Get the best of CNBC in your inbox
Get these newsletters delivered to your inbox, and more info about our products and service. Privacy Policy.▲
